MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.msard.2023.104940

Медицинская библиотека · Multiple sclerosis and related disorders · 2023

Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement.

Karaaslan Zerrin, Şengül-Yediel Büşra, Yüceer-Korkmaz Hande, Şanlı Elif, Gezen-Ak Duygu, Dursun Erdinç, Timirci-Kahraman Özlem, Baykal Ahmet Tarık, Yılmaz Vuslat, Türkoğlu Recai, Kürtüncü Murat, Gündüz Tuncay, Gürsoy-Özdemir Yasemin, Tüzün Erdem, İsmail Küçükali Cem

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Antibodies to cell surface proteins of astrocytes have been described in chronic inflammatory demyelinating disorders (CIDD) of the central nervous system including multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Our aim was to identify novel anti-astrocyte autoantibodies in relapsing remitting MS (RRMS) patients presenting predominantly with spinal cord and optic nerve attacks (MS-SCON).

METHODS

Sera of 29 MS-SCON patients and 36 healthy controls were screened with indirect immunofluorescence to identify IgG reacting with human astrocyte cultures. Putative target autoantigens were investigated with immunoprecipitation (IP) and liquid chromatography-mass/mass spectrometry (LC-MS/MS) studies using cultured human astrocytes. Validation of LC-MS/MS results was carried out by IP and ELISA.

RESULTS

Antibodies to astrocytic cell surface antigens were detected in 5 MS-SCON patients by immunocytochemistry. LC-MS/MS analysis identified chloride intracellular channel protein-1 (CLIC1) as the single common membrane antigen in 2 patients with MS-SCON. IP experiments performed with the commercial CLIC1 antibody confirmed CLIC1-antibody. Home made ELISA using recombinant CLIC1 protein as the target antigen identified CLIC1 antibodies in 9/29 MS-SCON and 3/15 relapsing inflammatory optic neuritis (RION) patients but in none of the 30 NMOSD patients, 36 RRMS patients with only one or no myelitis/optic neuritis attacks and 36 healthy controls. Patients with CLIC1-antibodies showed trends towards exhibiting reduced disability scores.

CONCLUSION

CLIC1-antibody was identified for the first time in MS and RION patients, confirming once again anti-astrocytic autoimmunity in CIDD. CLIC1-antibody may potentially be utilized as a diagnostic biomarker for differentiation of MS from NMOSD.

Для цитирования: Karaaslan Zerrin, Şengül-Yediel Büşra, Yüceer-Korkmaz Hande, Şanlı Elif, Gezen-Ak Duygu, Dursun Erdinç, Timirci-Kahraman Özlem, Baykal Ahmet Tarık, Yılmaz Vuslat, Türkoğlu Recai, Kürtüncü Murat, Gündüz Tuncay, Gürsoy-Özdemir Yasemin, Tüzün Erdem, İsmail Küçükali Cem. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement.. Multiple sclerosis and related disorders. 2023. DOI: 10.1016/j.msard.2023.104940.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.